Blueprint Medicines’ (BPMC) “Market Perform” Rating Reaffirmed at JMP Securities
Blueprint Medicines (NASDAQ:BPMC – Get Free Report)‘s stock had its “market perform” rating reissued by JMP Securities in a research note issued to investors on Tuesday,Benzinga reports. A number of other research analysts also recently commented on BPMC. Morgan Stanley assumed coverage on shares of Blueprint Medicines in a research note on Thursday, March 20th. […]
Blueprint Medicines (NASDAQ:BPMC – Get Free Report)‘s stock had its “market perform” rating reissued by JMP Securities in a research note issued to investors on Tuesday,Benzinga reports. A number of other research analysts also recently commented on BPMC. Morgan Stanley assumed coverage on shares of Blueprint Medicines in a research note on Thursday, March 20th. […]
